147 related articles for article (PubMed ID: 29147173)
1. Targeting RhoC by Way of Ribozyme Trangene in Human Breast Cancer Cells and its Impact on Cancer Invasion.
Lane J; Martin TA; Jiang WG
World J Oncol; 2010 Feb; 1(1):7-13. PubMed ID: 29147173
[TBL] [Abstract][Full Text] [Related]
2. Targeting matrilysin and its impact on tumor growth in vivo: the potential implications in breast cancer therapy.
Jiang WG; Davies G; Martin TA; Parr C; Watkins G; Mason MD; Mokbel K; Mansel RE
Clin Cancer Res; 2005 Aug; 11(16):6012-9. PubMed ID: 16115946
[TBL] [Abstract][Full Text] [Related]
3. Targeting the HGF/SF receptor c-met using a hammerhead ribozyme transgene reduces in vitro invasion and migration in prostate cancer cells.
Davies G; Watkins G; Mason MD; Jiang WG
Prostate; 2004 Sep; 60(4):317-24. PubMed ID: 15264243
[TBL] [Abstract][Full Text] [Related]
4. "Smart" Nanoparticles Enhance the Cytoplasmic Delivery of Anti-RhoC Silencing RNA and Inhibit the Migration and Invasion of Aggressive Breast Cancer Cells.
Kaushal N; Durmaz YY; Bao L; Merajver SD; ElSayed ME
Mol Pharm; 2015 Jul; 12(7):2406-17. PubMed ID: 26020100
[TBL] [Abstract][Full Text] [Related]
5. Reduction of stromal fibroblast-induced mammary tumor growth, by retroviral ribozyme transgenes to hepatocyte growth factor/scatter factor and its receptor, c-MET.
Jiang WG; Grimshaw D; Martin TA; Davies G; Parr C; Watkins G; Lane J; Abounader R; Laterra J; Mansel RE
Clin Cancer Res; 2003 Sep; 9(11):4274-81. PubMed ID: 14519655
[TBL] [Abstract][Full Text] [Related]
6. A hammerhead ribozyme suppresses expression of hepatocyte growth factor/scatter factor receptor c-MET and reduces migration and invasiveness of breast cancer cells.
Jiang WG; Grimshaw D; Lane J; Martin TA; Abounader R; Laterra J; Mansel RE
Clin Cancer Res; 2001 Aug; 7(8):2555-62. PubMed ID: 11489839
[TBL] [Abstract][Full Text] [Related]
7. Expression of membrane type-1 matrix metalloproteinase, MT1-MMP in human breast cancer and its impact on invasiveness of breast cancer cells.
Jiang WG; Davies G; Martin TA; Parr C; Watkins G; Mason MD; Mansel RE
Int J Mol Med; 2006 Apr; 17(4):583-90. PubMed ID: 16525713
[TBL] [Abstract][Full Text] [Related]
8. Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer.
Chang XZ; Li DQ; Hou YF; Wu J; Lu JS; Di GH; Jin W; Ou ZL; Shen ZZ; Shao ZM
Breast Cancer Res; 2007; 9(6):R76. PubMed ID: 17980029
[TBL] [Abstract][Full Text] [Related]
9. Genetic manipulation of stromal cell-derived factor-1 attests the pivotal role of the autocrine SDF-1-CXCR4 pathway in the aggressiveness of breast cancer cells.
Kang H; Mansel RE; Jiang WG
Int J Oncol; 2005 May; 26(5):1429-34. PubMed ID: 15809737
[TBL] [Abstract][Full Text] [Related]
10. Phospholipase-C gamma-1 (PLCgamma-1) is critical in hepatocyte growth factor induced in vitro invasion and migration without affecting the growth of prostate cancer cells.
Davies G; Martin TA; Ye L; Lewis-Russell JM; Mason MD; Jiang WG
Urol Oncol; 2008; 26(4):386-91. PubMed ID: 18367108
[TBL] [Abstract][Full Text] [Related]
11. [Correlation of expression of RhoC with invasiveness of breast cancer cells in vitro].
Yuan Z; Su J; You JF; Wang JL; Cui XL; Zheng J
Zhonghua Zhong Liu Za Zhi; 2007 Dec; 29(12):898-903. PubMed ID: 18478927
[TBL] [Abstract][Full Text] [Related]
12. Expression of the prostate transglutaminase (TGase-4) in prostate cancer cells and its impact on the invasiveness of prostate cancer.
Davies G; Ablin RJ; Mason MD; Jiang WG
J Exp Ther Oncol; 2007; 6(3):257-64. PubMed ID: 17552366
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the roles of RHOC and RHOA GTPases in invasion, motility, and matrix adhesion in inflammatory and aggressive breast cancers.
Wu M; Wu ZF; Rosenthal DT; Rhee EM; Merajver SD
Cancer; 2010 Jun; 116(11 Suppl):2768-82. PubMed ID: 20503409
[TBL] [Abstract][Full Text] [Related]
14. Myosin-interacting guanine exchange factor (MyoGEF) regulates the invasion activity of MDA-MB-231 breast cancer cells through activation of RhoA and RhoC.
Wu D; Asiedu M; Wei Q
Oncogene; 2009 Jun; 28(22):2219-30. PubMed ID: 19421144
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of human antigen R reduces the growth and invasion of breast cancer cells in vitro and affects expression of cyclin D1 and MMP-9.
Yuan Z; Sanders AJ; Ye L; Wang Y; Jiang WG
Oncol Rep; 2011 Jul; 26(1):237-45. PubMed ID: 21503589
[TBL] [Abstract][Full Text] [Related]
16. The expression of the von Hippel-Lindau gene product and its impact on invasiveness of human breast cancer cells.
Zia MK; Rmali KA; Watkins G; Mansel RE; Jiang WG
Int J Mol Med; 2007 Oct; 20(4):605-11. PubMed ID: 17786294
[TBL] [Abstract][Full Text] [Related]
17. Potential Implication of Paxillin in Cancer Establishment Within the Bone Environment.
Sobkowicz AD; Sanders AJ; Mason MD; Jiang WG
Anticancer Res; 2017 Aug; 37(8):4255-4268. PubMed ID: 28739717
[TBL] [Abstract][Full Text] [Related]
18. Synergistic inhibition of aggressive breast cancer cell migration and invasion by cytoplasmic delivery of anti-RhoC silencing RNA and presentation of EPPT1 peptide on "smart" particles.
Kaushal N; Tiruchinapally G; Durmaz YY; Bao L; Gilani R; Merajver SD; ElSayed MEH
J Control Release; 2018 Nov; 289():79-93. PubMed ID: 30149048
[TBL] [Abstract][Full Text] [Related]
19. Hyaluronan-CD44 interaction promotes c-Src-mediated twist signaling, microRNA-10b expression, and RhoA/RhoC up-regulation, leading to Rho-kinase-associated cytoskeleton activation and breast tumor cell invasion.
Bourguignon LY; Wong G; Earle C; Krueger K; Spevak CC
J Biol Chem; 2010 Nov; 285(47):36721-35. PubMed ID: 20843787
[TBL] [Abstract][Full Text] [Related]
20. Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo.
Pillé JY; Denoyelle C; Varet J; Bertrand JR; Soria J; Opolon P; Lu H; Pritchard LL; Vannier JP; Malvy C; Soria C; Li H
Mol Ther; 2005 Feb; 11(2):267-74. PubMed ID: 15668138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
